Volume-Based Consolidation-to-Tumor Ratio Is a Useful Predictor for Postoperative Upstaging in Stage I and II Lung Adenocarcinomas.

Masanori ShimomuraMasashi IwasakiShunta IshiharaMasayoshi Inoue

Published in: The Thoracic and cardiovascular surgeon (2019)

Volume-based CTR could be a useful predictor for accurate clinical staging in stage I and II adenocarcinoma patients in addition to consolidation size, serum CEA level, and 2D-CTR. Both volume-based and 2D-CTRs might be especially useful in T1 diseases.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
lymph node
patient reported outcomes
radiation therapy
locally advanced
patient reported
rectal cancer